Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Iron Isomaltoside Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy: A Randomized Comparative Trial

NCT05251493 is registered in ClinicalTrials.gov with Saskatchewan Health Authority - Regina Area as lead sponsor.

NCT NCT05251493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05251493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Iron Isomaltoside Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy: A Randomized Comparative Trial
Lead sponsor
Saskatchewan Health Authority - Regina Area
Phase
Phase 3
Overall status
Recruiting
Start date
June 6, 2022
Completion date
February 28, 2027
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anaemia in childbirth